195 related articles for article (PubMed ID: 16914212)
1. Replication efficiency of chimeric replicon containing NS5A-5B genes derived from HCV-infected patient sera.
Tripathi RL; Krishnan P; He Y; Middleton T; Pilot-Matias T; Chen CM; Lau DT; Lemon SM; Mo H; Kati W; Molla A
Antiviral Res; 2007 Jan; 73(1):40-9. PubMed ID: 16914212
[TBL] [Abstract][Full Text] [Related]
2. Replication studies using genotype 1a subgenomic hepatitis C virus replicons.
Gu B; Gates AT; Isken O; Behrens SE; Sarisky RT
J Virol; 2003 May; 77(9):5352-9. PubMed ID: 12692237
[TBL] [Abstract][Full Text] [Related]
3. Transient replication of a hepatitis C virus genotype 1b replicon chimera encoding NS5A-5B from genotype 3a.
Kylefjord H; Danielsson A; Sedig S; Belda O; Wiktelius D; Vrang L; Targett-Adams P
J Virol Methods; 2014 Jan; 195():156-63. PubMed ID: 24120570
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a replicon-based phenotypic assay for assessing HCV NS4B from clinical isolates.
Rajyaguru S; Yang H; Martin R; Miller MD; Mo H
Antiviral Res; 2013 Nov; 100(2):328-36. PubMed ID: 24013002
[TBL] [Abstract][Full Text] [Related]
5. Replication-competent chimeric hepatitis C virus subgenomic replicons.
Lemm JA; Liu M; Rose RE; Fridell R; O'Boyle Ii DR; Colonno R; Gao M
Intervirology; 2005; 48(2-3):183-91. PubMed ID: 15812193
[TBL] [Abstract][Full Text] [Related]
6. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.
Ikeda M; Yi M; Li K; Lemon SM
J Virol; 2002 Mar; 76(6):2997-3006. PubMed ID: 11861865
[TBL] [Abstract][Full Text] [Related]
7. Replication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assay.
Ludmerer SW; Graham DJ; Boots E; Murray EM; Simcoe A; Markel EJ; Grobler JA; Flores OA; Olsen DB; Hazuda DJ; LaFemina RL
Antimicrob Agents Chemother; 2005 May; 49(5):2059-69. PubMed ID: 15855532
[TBL] [Abstract][Full Text] [Related]
8. Dominant negative effect of wild-type NS5A on NS5A-adapted subgenomic hepatitis C virus RNA replicon.
Graziani R; Paonessa G
J Gen Virol; 2004 Jul; 85(Pt 7):1867-1875. PubMed ID: 15218171
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus genotype 1b chimeric replicon containing genotype 3 NS5A domain.
Lanford RE; Guerra B; Lee H
Virology; 2006 Nov; 355(2):192-202. PubMed ID: 16919701
[TBL] [Abstract][Full Text] [Related]
10. Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon.
Shimakami T; Hijikata M; Luo H; Ma YY; Kaneko S; Shimotohno K; Murakami S
J Virol; 2004 Mar; 78(6):2738-48. PubMed ID: 14990694
[TBL] [Abstract][Full Text] [Related]
11. A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A background.
Graham DJ; Stahlhut M; Flores O; Olsen DB; Hazuda DJ; Lafemina RL; Ludmerer SW
Antiviral Res; 2006 Jan; 69(1):24-30. PubMed ID: 16297457
[TBL] [Abstract][Full Text] [Related]
12. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
Lanford RE; Guerra B; Lee H; Averett DR; Pfeiffer B; Chavez D; Notvall L; Bigger C
J Virol; 2003 Jan; 77(2):1092-104. PubMed ID: 12502825
[TBL] [Abstract][Full Text] [Related]
13. Development of full-length cell-culture infectious clone and subgenomic replicon for a genotype 3a isolate of hepatitis C virus.
Chen M; Xu Y; Li N; Yin P; Zhou Q; Feng S; Wu T; Wei L; Wang H; Fu Y; Li YP
J Gen Virol; 2021 Dec; 102(12):. PubMed ID: 34949310
[TBL] [Abstract][Full Text] [Related]
14. Trans-complementation of HCV replication by non-structural protein 5A.
Tong X; Malcolm BA
Virus Res; 2006 Feb; 115(2):122-30. PubMed ID: 16146661
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus.
Bilello JP; Lallos LB; McCarville JF; La Colla M; Serra I; Chapron C; Gillum JM; Pierra C; Standring DN; Seifer M
Antimicrob Agents Chemother; 2014 Aug; 58(8):4431-42. PubMed ID: 24867983
[TBL] [Abstract][Full Text] [Related]
16. Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture.
Yu M; Peng B; Chan K; Gong R; Yang H; Delaney W; Cheng G
Antimicrob Agents Chemother; 2014 May; 58(5):2638-46. PubMed ID: 24550344
[TBL] [Abstract][Full Text] [Related]
17. Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems.
Camus G; Xu S; Han B; Lu J; Dvory-Sobol H; Yu M; Cheng G; Miller MD; Doehle BP; Mo H
Virology; 2018 Jan; 514():134-141. PubMed ID: 29175627
[TBL] [Abstract][Full Text] [Related]
18. A link between translation of the hepatitis C virus polyprotein and polymerase function; possible consequences for hyperphosphorylation of NS5A.
McCormick CJ; Brown D; Griffin S; Challinor L; Rowlands DJ; Harris M
J Gen Virol; 2006 Jan; 87(Pt 1):93-102. PubMed ID: 16361421
[TBL] [Abstract][Full Text] [Related]
19. Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems.
Lin HM; Wang JC; Hu HS; Wu PS; Wang WH; Wu SY; Yang CC; Yeh TK; Hsu TA; Jiaang WT; Chao YS; Chern JH; Yueh A
Antimicrob Agents Chemother; 2013 Feb; 57(2):723-33. PubMed ID: 23165461
[TBL] [Abstract][Full Text] [Related]
20.
Ng TI; Krishnan P; Pilot-Matias T; Kati W; Schnell G; Beyer J; Reisch T; Lu L; Dekhtyar T; Irvin M; Tripathi R; Maring C; Randolph JT; Wagner R; Collins C
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
